Skip to main content

People in the News: Bernd Brust

Premium

Bernd Brust has resigned as the president of molecular medicine at Life Technologies "in order to pursue other opportunities," the company said in a filing with the US Securities and Exchange Commission this week. Brust has led the molecular medicine business unit since January, when it was created to help the company transition to next-gen sequencing in the clinic. He previously was Life Tech's president of commercial operations. Life Tech said that Brust will continue to serve as a consultant through Dec. 31 "to assist the company with various endeavors."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.